Showing results (231-240 of 258) with videos related to
Sort By:
Pageof 26
Calcified Tissue International|October 28, 2010
Imatinib mesylate does not increase bone volume in vivoSusannah O'Sullivan, Dorit Naot, Karen E Callon, et al.Bone|October 4, 2005
Evaluation of the role of Valosin-containing protein in the pathogenesis of familial and sporadic Paget's disease of boneGavin J A Lucas, Sarju G Mehta, Lynne J Hocking, et al.The New Zealand Medical Journal|September 28, 2011
Prevalent dietary supplement use in older New Zealand menCatherine J Bacon, Mark J Bolland, Ruth W Ames, et al.The New England Journal of Medicine|January 15, 2025
Fracture Prevention with Infrequent Zoledronate in Women 50 to 60 Years of AgeMark J Bolland, Zaynah Nisa, Anna Mellar, et al.The Journal of Clinical Endocrinology and Metabolism|March 16, 2012
Effects of intravenous zoledronate on bone turnover and bone density persist for at least five years in HIV-infected menMark J Bolland, Andrew Grey, Anne M Horne, et al.Clinical Endocrinology|November 2, 2011
Stable bone mineral density over 6 years in HIV-infected men treated with highly active antiretroviral therapy (HAART)Mark J Bolland, Andrew Grey, Anne M Horne, et al.The Journal of Clinical Endocrinology and Metabolism|October 17, 2025
Anti-fracture efficacy of 5- or 10- yearly zoledronate in women aged 50-60y: secondary analyses of a randomized trialMark J Bolland, Zaynah Nisa, Anna Mellar, et al.The American Journal of Clinical Nutrition|November 13, 2009
Effects of calcium supplementation on lipids, blood pressure, and body composition in healthy older men: a randomized controlled trialIan R Reid, Ruth Ames, Barbara Mason, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 5, 2004
Novel UBA domain mutations of SQSTM1 in Paget's disease of bone: genotype phenotype correlation, functional analysis, and structural consequencesLynne J Hocking, Gavin J A Lucas, Anna Daroszewska, et al.Schizophrenia Research|December 28, 2010
The atypical anti-psychotic clozapine decreases bone mass in rats in vivoJessica L Costa, Greg Smith, Maureen Watson, et al.Pageof 26